The Cybersecurity and Infrastructure Security Agency yesterday alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures. According to an IBM X-Force report, cyber actors impersonating a biomedical company have sent emails to executives and global organizations involved in COVID-19 vaccine storage and transport to harvest credentials. The emails have posed as requests for quotations to participate in a vaccine program. CISA encourages organizations to review the report for more information.

John Riggi, AHA senior advisor for cyber and risk, said, “This alert demonstrates the need to remain vigilant and educate staff of the perils of phishing emails, the number one attack vector by cyber adversaries, because frankly it works and is fairly simple. However, the impact of clicking on a phishing email in the context of vaccine distribution could have broad public health implications.”

For more on cybersecurity and risk issues, hospital and health system leaders may contact Riggi at jriggi@aha.org.

Related News Articles

Headline
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used…
Headline
The National Security Agency, Cybersecurity and Infrastructure Security Agency and international partners May 22 released guidance on securing data used for…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
The FBI, along with the National Security Agency and other international cybersecurity agencies, this week released a joint agency advisory on cyber operations…
Headline
The FBI's Internet Crime Complaint Center released an alert May 7 warning of cyber actors exploiting vulnerabilities in end-of-life routers. Routers dated 2010…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…